Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 20/20 | 0.53 |
| ▸ | AKT2 | P31751 | 11/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 10/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31455009 | 0.99 | AKT1 (0.54) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455174 | 0.92 | AKT1 (0.52) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455307 | 0.88 | AKT1 (0.62) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455306 | 0.85 | AKT1 (0.57) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455393 | 0.85 | AKT1 (0.61) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455219 | 0.84 | AKT1 (0.53) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455075 | 0.83 | AKT1 (0.59) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455479 | 0.83 | AKT1 (0.51) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455168 | 0.82 | AKT1 (0.61) | AKT1AKT2AKT3CYP2D6CYP2C9 | |
| SCHEMBL31455166 | 0.80 | AKT1 (0.50) | AKT1AKT2AKT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |